SCHEMBL976750

SCHEMBL976750

O=Cc1ccccc1-c1cccc(C=O)c1-c1ccccc1C=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.52
KMT2A Q03164 2/20 0.52
MEN1 O00255 1/20 0.52
THRB P10828 1/20 0.52
BLM P54132 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
ALDH1A1 P00352 3/20 0.43
TRIM24 O15164 2/20 0.43
TRIM33 Q9UPN9 2/20 0.43
TSHR P16473 1/20 0.43
ERN1 O75460 4/20 0.40
HPGD P15428 1/20 0.39
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
XDH P47989 1/20 0.39
KCNN4 O15554 1/20 0.36
GAA P10253 1/20 0.36
CYP2A6 P11509 2/20 0.35
TLR2 O60603 1/20 0.34
TLR1 Q15399 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3612898 0.88 LMNA (0.55) LMNAKMT2AMEN1THRBBLM
SCHEMBL30086144 0.88 LMNA (0.55) LMNAKMT2AMEN1THRBBLM
SCHEMBL249552 0.85 KMT2A (0.71) LMNAKMT2AMEN1THRBBLM
SCHEMBL31175932 0.85 KMT2A (0.71) LMNAKMT2AMEN1THRBBLM
SCHEMBL31588841 0.83 KMT2A (0.67) LMNAKMT2AMEN1THRBBLM
SCHEMBL27511393 0.83 KMT2A (0.67) LMNAKMT2AMEN1THRBBLM
SCHEMBL3364887 0.81 MEN1 (0.46) LMNAKMT2AMEN1THRBBLM
SCHEMBL6535649 0.81 TDP1 (0.46) LMNAKMT2AMEN1THRBBLM
SCHEMBL3880759 0.81 ADORA2A (0.47) LMNAKMT2AMEN1THRBBLM
Phenol SCHEMBL3738233 0.79 TRIM24 (0.47) LMNAKMT2AMEN1THRBBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240366629-A1 Porphyrin Complexes as Antidotes for Carbon Monoxide Exposure and Methods of Use for Same UNIV CALIFORNIA (US) 2024-11-07 US disclosed
EP-4395773-A1 PORPHYRIN COMPLEXES AS ANTIDOTES FOR CARBON MONOXIDE EXPOSURE AND METHODS OF USE FOR SAME The Regents of the University of California (US) 2024-07-10 EP disclosed
WO-2023034447-A9 PORPHYRIN COMPLEXES AS ANTIDOTES FOR CARBON MONOXIDE EXPOSURE AND METHODS OF USE FOR SAME THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-04-20 WO disclosed
WO-2023034447-A1 PORPHYRIN COMPLEXES AS ANTIDOTES FOR CARBON MONOXIDE EXPOSURE AND METHODS OF USE FOR SAME THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-03-09 WO disclosed
CN-114230448-A Aromatic aldehyde compound of covalent-organic framework material and preparation method thereof 南京艾姆材料科技有限公司 2022-03-25 CN disclosed
CN-107531598-B Compositions for treating fibrosis and fibrosis-related disorders 维克图斯生物系统有限公司 2020-10-16 CN disclosed
EP-1739485-B1 RESIST COMPOSITION MITSUBISHI GAS CHEMICAL CO (JP) 2016-08-31 EP disclosed
US-7871751-B2 Resist composition MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2011-01-18 US disclosed
US-20080153031-A1 Resist composition MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2008-06-26 US disclosed
EP-1739485-A1 RESIST COMPOSITION MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2007-01-03 EP disclosed
US-3968159-A Process for preparing azomethines MONSANTO COMPANY (US) 1976-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240366629-A1 Porphyrin Complexes as Antidotes for Carbon Monoxide Exposure and Methods of Use for Same MB, HMBS, HMOX2 LMNA 1804/4885KMT2A 2703/4885MEN1 4417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.